Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nina Nordin"'
Autor:
Tomas Olsson, Johan Askling, Thomas Frisell, C Kiesel, Fredrik Piehl, Lars Alfredsson, Nina Nordin, Lars Forsberg, Jan Hillert
Publikováno v:
Multiple Sclerosis Journal. 22:85-93
Background: Natalizumab (NTZ) and fingolimod (FGL) are mainly used second line in relapsing–remitting multiple sclerosis (MS), although pivotal trials included mainly treatment-naïve patients. Objective: This study aims to provide real-world data
Autor:
E. Sundqvist, Anna Karin Hedström, Lars Alfredsson, Nina Nordin, Jan Hillert, Tomas Olsson, Ingrid Kockum, Maria Bäärnhielm
Publikováno v:
Brain. 134:653-664
Both genetic and environmental factors display low or modest associations with multiple sclerosis. Hypothetically, gene-environment interactions may exert much stronger effects. In this study, we investigated potential interactions between genetic ri
Autor:
Verena I. Leussink, Kathleen Wolfram, Ryan Ramanujam, Nina Nordin, Thomas Dehmel, Carolina Holmén, Tomas Olsson, Clemens Warnke, Bernd C. Kieseier, Hans-Peter Hartung
Publikováno v:
Neurology. 83(23)
Objective: To assess whether pretreatment-lymphocyte counts, treatment before fingolimod, age, sex, or body mass index (BMI) affects the risk of fingolimod-induced lymphopenia in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: D